ALXA (ALXA) Stock Price, News & Analysis

Company Overview

Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Its product also includes ADASUVE, which contains loxapine as API is developed for the treatment of agitation associated with schizophrenia or bipolar disorder. It has initiated a Phase IIa proof-of-concept study for AZ-002 in patients with epilepsy and has completed Phase I testing for AZ-007.

Key Stats

• Today's Range: $0.94 to $0.94
• 50-Day Range: N/A
• 52-Week Range: $0.22 to $1.60
• Volume: 100 shs
• Average Volume: 158,340 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALXA Stock Analysis - Frequently Asked Questions

How were ALXA's earnings last quarter?

ALXA (OTCMKTS:ALXA) posted its earnings results on Wednesday, May, 11th. The healthcare company reported ($0.16) EPS for the quarter. The healthcare company had revenue of $0.72 million for the quarter.

What other stocks do shareholders of ALXA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ALXA investors own include Anavex Life Sciences (AVXL), Pernix Therapeutics (PTX), BioDelivery Sciences International (BDSI), PayPal (PYPL), Achillion Pharmaceuticals (ACHN), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Company Calendar

• Last Earnings: 5/11/2016
• Today: 2/11/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ALXA
• Previous Symbol: NASDAQ:ALXA
• CUSIP: N/A
• CIK: 1344413
• Web: www.alexza.com
• Phone: +1-650-9447000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A